NCT01148667View on ClinicalTrials.gov

Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Gut MicrobiotaSkin MicrobiotaHumoral Immune ResponsesSeverity of Atopic Dermatitis
Interventions
DIETARY_SUPPLEMENT

Casein hydrolysate added with LGG

Infants drink extensively hydrolysed casein formula supplemented with LGG (ATCC 53103) 5.0 x 10 7 cfu/g to achieve a daily intake of 3.4 10 9 cfu.

DIETARY_SUPPLEMENT

Infants drink casein hydrolysate without LGG

Infants drink extensively hydrolysed casein formula without added LGG

Trial Locations (1)

20520

Turku University Central Hospital, Turku

All Listed Sponsors
collaborator

Academy of Finland

OTHER

collaborator

Mead Johnson Nutrition

INDUSTRY

lead

Turku University Hospital

OTHER_GOV

NCT01148667 - Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity | Biotech Hunter | Biotech Hunter